LLX Solutions was founded by three experienced clinical trialists with excellent reputation in the bio/pharmaceutical, medical device, and consulting services industries. Our hard works and outstanding contributions to our previous companies and clients have won the trust of our industry colleagues. We understand the difficulties and challenges you face so that we always do our best to find the most efficient and cost-effective solutions to your projects.
Liang has over 20 years of clinical and preclinical experience in drug development, of which more than 8 years he has been working in bio/pharmaceutical and medical device industry as a lead or consultant biostatistician. He has extensive experience in design and analysis of Phase I to IV clinical trials and registries. He has participated in and led statistical efforts in multiple U.S. and international submissions, and the FDA Advisory Committee (Panel) Meetings. He has diverse management experience for projects conducted in-house and by CROs, and collaborated with expert statistical consultants, medical directors/principal investigators on key study design and publications. He has deep understanding of FDA/EMEA/HC/PMDA and ICH guidelines, and their implementations. He is more than happy to be part of your success by assisting you team with high quality services.
Frank Xin has more than 20 years clinical trials experience in pharmaceutical and biotech industry, especially expertise on statistical programming outputs – CDISC/SDTM/ADaM, Utility Macros, and other clinical study reports creation. With experience at both CRO And pharma/biotech companies, Frank has excellent interaction skills with internal and external relationships and management of programming project strategies and processes throughout the life of a particular project. Before join LLX Solutions, Frank ever helped business development as Sr. Director in Clinmedics.